Colonial Trust’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$186K Sell
2,060
-10
-0.5% -$918 0.03% 306
2025
Q4
$186K Buy
2,070
+393
+23% +$37.3K 0.02% 311
2025
Q3
$165K Sell
1,677
-593
-26% -$58.8K 0.02% 346
2025
Q2
$207K Sell
2,270
-100
-4% -$9.67K 0.03% 297
2025
Q1
$268K Sell
2,370
-4
-0.2% -$428 0.04% 241
2024
Q4
$251K Sell
2,374
-140
-6% -$15K 0.04% 260
2024
Q3
$271K Buy
2,514
+3
+0.1% +$327 0.04% 251
2024
Q2
$273K Buy
2,511
+541
+27% +$63.8K 0.05% 225
2024
Q1
$260K Sell
1,970
-109
-5% -$13.6K 0.05% 236
2023
Q4
$253K Hold
2,079
0.05% 227
2023
Q3
$233K Sell
2,079
-9
-0.4% -$1.14K 0.06% 205
2023
Q2
$304K Buy
2,088
+442
+27% +$60.1K 0.07% 177
2023
Q1
$213K Sell
1,646
-22
-1% -$2.76K 0.05% 223
2022
Q4
$213K Buy
+1,668
New +$194K 0.06% 198

Other funds holding ZBH

Colonial Trust's ZBH Position: Q1 2026 in Review

Colonial Trust reduced its Zimmer Biomet (ZBH) stake by 0.48% in Q1 2026, selling an estimated $918 and leaving 2,060 shares worth $186K. The position accounts for 0.03% of the portfolio, ranked #306.

Colonial Trust first reported a position in ZBH in Q4 2022 and has held it in 14 quarters since. The position peaked at $304K in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Colonial Trust held 2,060 shares of Zimmer Biomet worth $186K as of Q1 2026.
  • Colonial Trust sold 10 Zimmer Biomet shares in Q1 2026, an estimated $918.
  • Zimmer Biomet made up 0.03% of Colonial Trust's portfolio in Q1 2026, its #306 holding.
  • Colonial Trust first reported a position in Zimmer Biomet in Q4 2022 and has held it in 14 quarters since.
  • Colonial Trust's Zimmer Biomet position peaked at $304K in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Colonial Trust's 13F filing for Q1 2026, filed 12 May 2026.